Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by crow27 on Jan 11, 2021 4:34pm

$4.13

Is much better than $3.40. It traded that low just 13 trading days ago.  People are interested and that's what counts.
Comment by 3burtc on Jan 11, 2021 4:47pm
Investors see through the lies. Everyone and their dogs knows no delusion happened or will happen. Just strait up lies. The tiny delay is nothing compared to the billions, & billions that we be made. Glt the new guys & girls & welcome.
Comment by ABCs123s on Jan 11, 2021 6:26pm
  I mean dilution did happen post phase 2 results, but will dilution happen? That certainly is a possibility, they still need cash to cover phase 3, if theirs no partner/buyout. Theirs also a possibility of dilution with the amalgation of holdings into therapeutics.
Comment by MrMugsy on Jan 11, 2021 6:55pm
Yes ... need to assume the company will be able to get the share price up and there will also be some dilution coming.  Hoping it to be a smaller dilution based on share price appreciation ... to keep the ship running. Hey, if they can make it happen without dilution, great!  But probably not the best assumption to make at this time.   IMO ----
Comment by 3burtc on Jan 11, 2021 8:48pm
Dilution lie continues.......
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities